Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8 super(+) T cell population in different tissues
Directed dissemination of Ag-specific CD8 super(+) T cells to infected organs or cancerous tissues is a prerequisite for optimal immunotherapy. Ag-specific CD8 super(+) T cells were quantitated in systemic and mucosal tissues after nasal, rectal, or cutaneous immunization with CTL epitope peptide an...
Gespeichert in:
Veröffentlicht in: | Vaccine 2004-03, Vol.22 (11-12), p.1390-1394 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1394 |
---|---|
container_issue | 11-12 |
container_start_page | 1390 |
container_title | Vaccine |
container_volume | 22 |
creator | Qimron, U Paul, L Bar-Haim, E Bloushtain, N Eisenbach, L Staats, H F Porgador, A |
description | Directed dissemination of Ag-specific CD8 super(+) T cells to infected organs or cancerous tissues is a prerequisite for optimal immunotherapy. Ag-specific CD8 super(+) T cells were quantitated in systemic and mucosal tissues after nasal, rectal, or cutaneous immunization with CTL epitope peptide and the adjuvant cholera toxin (CT). Mucosal and cutaneous immunization induced Ag-specific CD8 super(+) lymphocytes that were detectable in both mucosal and systemic compartments, suggesting a less strict distribution pattern than that known for B cells. However, optimal localization, activation and phenotype of these cells correlated with the route of immunization. In accordance with this observation, protection against a mucosal challenge with a virus expressing the CTL epitope was superior in mucosally-immunized animals. |
doi_str_mv | 10.1016/j.vaccine.2003.11.043 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_17920209</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17920209</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_179202093</originalsourceid><addsrcrecordid>eNqNjLtOAzEQRV2ARHh8AtJUCITWjHeXwNKhAKKiSkEXWc5scOS1nR07Ej_Dt-KgpKe6mjvnHiEuFUqFanq3llttjPUka8RGKiWxbY7EBOtpW7UKP0_EKfMaEe8b1U3Ez0fw1UjRWaOT9SsYsgmsHWi_BP7mRIM1sHfyE2yy9smmwm7pjymFO9xL2_c0kjfEYD2kL4LnVcWRjO2LZfbyCJwjjde3NzAHQ85BDDG7sg5-tzgIEiTLnInPxXGvHdPFPs_E1dvrfPZexTFsyj8tBss7kfYUMi_UQ1djjV3zb_AXtStl6w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17920209</pqid></control><display><type>article</type><title>Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8 super(+) T cell population in different tissues</title><source>Elsevier ScienceDirect Journals</source><creator>Qimron, U ; Paul, L ; Bar-Haim, E ; Bloushtain, N ; Eisenbach, L ; Staats, H F ; Porgador, A</creator><creatorcontrib>Qimron, U ; Paul, L ; Bar-Haim, E ; Bloushtain, N ; Eisenbach, L ; Staats, H F ; Porgador, A</creatorcontrib><description>Directed dissemination of Ag-specific CD8 super(+) T cells to infected organs or cancerous tissues is a prerequisite for optimal immunotherapy. Ag-specific CD8 super(+) T cells were quantitated in systemic and mucosal tissues after nasal, rectal, or cutaneous immunization with CTL epitope peptide and the adjuvant cholera toxin (CT). Mucosal and cutaneous immunization induced Ag-specific CD8 super(+) lymphocytes that were detectable in both mucosal and systemic compartments, suggesting a less strict distribution pattern than that known for B cells. However, optimal localization, activation and phenotype of these cells correlated with the route of immunization. In accordance with this observation, protection against a mucosal challenge with a virus expressing the CTL epitope was superior in mucosally-immunized animals.</description><identifier>ISSN: 0264-410X</identifier><identifier>DOI: 10.1016/j.vaccine.2003.11.043</identifier><language>eng</language><ispartof>Vaccine, 2004-03, Vol.22 (11-12), p.1390-1394</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Qimron, U</creatorcontrib><creatorcontrib>Paul, L</creatorcontrib><creatorcontrib>Bar-Haim, E</creatorcontrib><creatorcontrib>Bloushtain, N</creatorcontrib><creatorcontrib>Eisenbach, L</creatorcontrib><creatorcontrib>Staats, H F</creatorcontrib><creatorcontrib>Porgador, A</creatorcontrib><title>Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8 super(+) T cell population in different tissues</title><title>Vaccine</title><description>Directed dissemination of Ag-specific CD8 super(+) T cells to infected organs or cancerous tissues is a prerequisite for optimal immunotherapy. Ag-specific CD8 super(+) T cells were quantitated in systemic and mucosal tissues after nasal, rectal, or cutaneous immunization with CTL epitope peptide and the adjuvant cholera toxin (CT). Mucosal and cutaneous immunization induced Ag-specific CD8 super(+) lymphocytes that were detectable in both mucosal and systemic compartments, suggesting a less strict distribution pattern than that known for B cells. However, optimal localization, activation and phenotype of these cells correlated with the route of immunization. In accordance with this observation, protection against a mucosal challenge with a virus expressing the CTL epitope was superior in mucosally-immunized animals.</description><issn>0264-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqNjLtOAzEQRV2ARHh8AtJUCITWjHeXwNKhAKKiSkEXWc5scOS1nR07Ej_Dt-KgpKe6mjvnHiEuFUqFanq3llttjPUka8RGKiWxbY7EBOtpW7UKP0_EKfMaEe8b1U3Ez0fw1UjRWaOT9SsYsgmsHWi_BP7mRIM1sHfyE2yy9smmwm7pjymFO9xL2_c0kjfEYD2kL4LnVcWRjO2LZfbyCJwjjde3NzAHQ85BDDG7sg5-tzgIEiTLnInPxXGvHdPFPs_E1dvrfPZexTFsyj8tBss7kfYUMi_UQ1djjV3zb_AXtStl6w</recordid><startdate>20040301</startdate><enddate>20040301</enddate><creator>Qimron, U</creator><creator>Paul, L</creator><creator>Bar-Haim, E</creator><creator>Bloushtain, N</creator><creator>Eisenbach, L</creator><creator>Staats, H F</creator><creator>Porgador, A</creator><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20040301</creationdate><title>Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8 super(+) T cell population in different tissues</title><author>Qimron, U ; Paul, L ; Bar-Haim, E ; Bloushtain, N ; Eisenbach, L ; Staats, H F ; Porgador, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_179202093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Qimron, U</creatorcontrib><creatorcontrib>Paul, L</creatorcontrib><creatorcontrib>Bar-Haim, E</creatorcontrib><creatorcontrib>Bloushtain, N</creatorcontrib><creatorcontrib>Eisenbach, L</creatorcontrib><creatorcontrib>Staats, H F</creatorcontrib><creatorcontrib>Porgador, A</creatorcontrib><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Qimron, U</au><au>Paul, L</au><au>Bar-Haim, E</au><au>Bloushtain, N</au><au>Eisenbach, L</au><au>Staats, H F</au><au>Porgador, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8 super(+) T cell population in different tissues</atitle><jtitle>Vaccine</jtitle><date>2004-03-01</date><risdate>2004</risdate><volume>22</volume><issue>11-12</issue><spage>1390</spage><epage>1394</epage><pages>1390-1394</pages><issn>0264-410X</issn><abstract>Directed dissemination of Ag-specific CD8 super(+) T cells to infected organs or cancerous tissues is a prerequisite for optimal immunotherapy. Ag-specific CD8 super(+) T cells were quantitated in systemic and mucosal tissues after nasal, rectal, or cutaneous immunization with CTL epitope peptide and the adjuvant cholera toxin (CT). Mucosal and cutaneous immunization induced Ag-specific CD8 super(+) lymphocytes that were detectable in both mucosal and systemic compartments, suggesting a less strict distribution pattern than that known for B cells. However, optimal localization, activation and phenotype of these cells correlated with the route of immunization. In accordance with this observation, protection against a mucosal challenge with a virus expressing the CTL epitope was superior in mucosally-immunized animals.</abstract><doi>10.1016/j.vaccine.2003.11.043</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0264-410X |
ispartof | Vaccine, 2004-03, Vol.22 (11-12), p.1390-1394 |
issn | 0264-410X |
language | eng |
recordid | cdi_proquest_miscellaneous_17920209 |
source | Elsevier ScienceDirect Journals |
title | Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8 super(+) T cell population in different tissues |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T23%3A29%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-replicating%20mucosal%20and%20systemic%20vaccines:%20quantitative%20and%20qualitative%20differences%20in%20the%20Ag-specific%20CD8%20super(+)%20T%20cell%20population%20in%20different%20tissues&rft.jtitle=Vaccine&rft.au=Qimron,%20U&rft.date=2004-03-01&rft.volume=22&rft.issue=11-12&rft.spage=1390&rft.epage=1394&rft.pages=1390-1394&rft.issn=0264-410X&rft_id=info:doi/10.1016/j.vaccine.2003.11.043&rft_dat=%3Cproquest%3E17920209%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17920209&rft_id=info:pmid/&rfr_iscdi=true |